RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES
Impact
The enactment of S2455 would amend existing insurance laws to ensure that patients diagnosed with cancer can access scalp cooling treatments without incurring additional out-of-pocket costs. By broadening insurance coverage to include scalp cooling systems, this bill seeks to mitigate the distress caused by chemotherapy-induced alopecia. Access to such treatments is expected to encourage more patients to undergo necessary chemotherapy, knowing they have the option to prevent significant hair loss, which can be a distressing side effect of the treatment.
Summary
S2455, introduced in the Rhode Island General Assembly, mandates insurance coverage for scalp cooling systems for cancer patients undergoing chemotherapy. The bill specifically aims to address the emotional and psychological impact of hair loss commonly associated with chemotherapy treatments. Beginning January 1, 2027, all individual and group hospital or medical expense insurance policies, as well as services plans, must include coverage for these scalp cooling devices that have been approved by the FDA. This provision is designed to support patients in maintaining their sense of normalcy during cancer treatment.
Contention
Despite the positive intentions behind S2455, there may be points of contention regarding its implementation. Some stakeholders might argue that mandating such coverage could increase insurance premiums or lead to constraints in insurance coverage terms. Moreover, there may be concerns about the possible exclusions for certain types of insurance policies, as the bill does not apply to all forms of coverage, such as Medicare supplements or long-term care plans. As discussions continue, it will be important to balance the interests of patients requiring these treatments with those of insurance providers.
Mandates insurance coverage for scalp cooling treatments for breast cancer patients undergoing chemotherapy to prevent hair loss during chemotherapy treatments.
Mandates all insurance contracts, plans or policies provide insurance coverage for the expense of diagnosing and treating infertility, for women between the ages of 25 and 42 years including preimplantation genetic diagnosis (PGD) in conjunction with IVF.
Requires health insurance plans to cover services provided by licensed certified professional midwives. Insurers must report utilization and cost data annually. Certain limited benefit policies are exempt.
Requires health insurance policies to cover licensed certified lactation counselor services for childbearing families. It also prohibits requiring supervision or duplicate payments for services and mandates annual reporting.
Requires health insurance policies to cover licensed certified lactation counselor services for childbearing families. It also prohibits requiring supervision or duplicate payments for services and mandates annual reporting.
Requires individual and group health insurance policies that provide pregnancy-related benefits to cover medically necessary expenses for diagnosis and treatment of infertility and standard fertility-preservation services.